- Home
- IE vs GERN Comparison
IE vs GERN Comparison
Compare IE & GERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IE
- GERN
- Stock Information
- Founded
- IE 2020
- GERN 1990
- Country
- IE United States
- GERN United States
- Employees
- IE N/A
- GERN N/A
- Industry
- IE Metal Mining
- GERN Biotechnology: Pharmaceutical Preparations
- Sector
- IE Basic Materials
- GERN Health Care
- Exchange
- IE Nasdaq
- GERN Nasdaq
- Market Cap
- IE 745.0M
- GERN 840.7M
- IPO Year
- IE 2022
- GERN 1996
- Fundamental
- Price
- IE $6.33
- GERN $1.39
- Analyst Decision
- IE Strong Buy
- GERN Buy
- Analyst Count
- IE 3
- GERN 11
- Target Price
- IE $12.17
- GERN $5.80
- AVG Volume (30 Days)
- IE 1.1M
- GERN 14.8M
- Earning Date
- IE 05-07-2025
- GERN 05-07-2025
- Dividend Yield
- IE N/A
- GERN N/A
- EPS Growth
- IE N/A
- GERN N/A
- EPS
- IE N/A
- GERN N/A
- Revenue
- IE $2,901,000.00
- GERN $76,994,000.00
- Revenue This Year
- IE $58.60
- GERN $208.83
- Revenue Next Year
- IE $0.74
- GERN $57.49
- P/E Ratio
- IE N/A
- GERN N/A
- Revenue Growth
- IE N/A
- GERN 32386.92
- 52 Week Low
- IE $4.50
- GERN $1.17
- 52 Week High
- IE $12.98
- GERN $5.34
- Technical
- Relative Strength Index (RSI)
- IE 54.81
- GERN 42.59
- Support Level
- IE $5.83
- GERN $1.17
- Resistance Level
- IE $6.66
- GERN $1.43
- Average True Range (ATR)
- IE 0.58
- GERN 0.13
- MACD
- IE 0.11
- GERN 0.03
- Stochastic Oscillator
- IE 84.72
- GERN 55.00
About IE Ivanhoe Electric Inc.
Ivanhoe Electric Inc is a United States-based d minerals exploration company with a focus on developing mines from mineral deposits principally located in the United States. The company has four business segments; Santa Cruz Project; critical metals; data processing services; and energy storage. It derives a majority of its revenue from Canada. The Santa Cruz Project and critical metals segments are focused on mineral project exploration and development. The data processing segment provides data analytics, geophysical modeling, and artificial intelligence services for the mineral, oil & gas, and water exploration industries. The energy storage segment develops, manufactures, and installs vanadium flow batteries for grid-scale energy storage.
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.